News | February 24, 2012

Remote Patient Monitoring Helps Improve Care Coordination, Lower Healthcare Costs

February 24, 2012 — Hospital readmissions continue to be a challenge nationwide. It has been estimated that chronic diseases such as asthma, congestive heart failure (CHF) and diabetes account for over 80 percent of hospital inpatient stays. CHF alone is the leading cause of hospital admissions for Americans over the age of 65.

Remote patient monitoring solutions are able to help patients spend more time at home than in the hospital, as well as improve care coordination and lower costs.

AT&T and Intuitive Health are working together to pilot a home-based remote patient monitoring solution that helps engage patients and family members in their own care, while seamlessly involving healthcare providers through integration with their clinical information systems. The goal is to help reduce hospital readmissions and healthcare costs, and increase quality of care and patient satisfaction.

AT&T provides wireless connectivity to send data from unobtrusive personal health devices including tablets, weight scales and pulse oximeters to a cloud-based, device-agnostic, software platform from Intuitive Health that engages patients in their homes and enables the data gathered to be shared with caregivers in a highly-secure manner.

To measure the effectiveness of the solution, AT&T and Intuitive Health have been collaborating with Texas Health Resources, one of the largest faith-based, nonprofit health systems in the United States. Texas Health's research arm, Texas Health Research & Education Institute, is leading an Institutional Review Board-approved study to measure reductions in heart failure readmissions. The study went live in April 2011 and is scheduled to conclude in December 2012. Preliminary results of the study indicate positive patient feedback and reduced readmissions.

The Texas Health Research & Education study monitors CHF patients for 90 days from their hospital discharge, provides the patients with tools to participate in their own care and helps identify potential issues early that could result in complications and re-admission. The overarching goal is to keep the patient in their home environment and functioning at the highest level possible while reducing the cost of re-hospitalization.

"Allowing providers and patients to interact remotely helps improve access to care and makes the likelihood of timely interventions much more possible," said Randall Porter, assistant vice president, AT&T ForHealth, AT&T Business Solutions.

"Innovation is desperately needed outside the four walls of the hospital," said Eric Rock, CEO and founder of Intuitive Health. "In order to increase our nation's quality of care and gain control of our healthcare spending, patients of all ages and technical ability must be given intuitive tools to improve their own health, while remaining engaged and monitored by their caregivers remotely."

Healthcare providers can see a demonstration of the remote patient monitoring solution at booth 3829 at the Healthcare and Information Management Systems Society 2012 (HIMSS12) in Las Vegas, Nev., from Feb. 20-24, 2012.

For more information: www.att.com

Related Content

First Patient Enrolled in U.S. Arm of ALIVE Pivotal Heart Failure Trial
News | Heart Failure| October 17, 2017
October 17, 2017 — BioVentrix Inc. recently announced enrollment of the first patient in the U.S.
Medtronic HeartWare HVAD System Approved for Destination Therapy
Technology | Ventricular Assist Devices (VAD)| October 04, 2017
October 4, 2017 — Medtronic received U.S.
Medical Metrics Taps Digisonics Cardiovascular Information Systems for Clinical Trials
News | Cardiac PACS| October 03, 2017
October 3, 2017 – Medical Metrics, an experienced core laboratory for multi-center clinical trials, has implemented t
Abiomed Receives FDA PMA Approval for Impella RP for Right Heart Failure
Technology | Ventricular Assist Devices (VAD)| September 28, 2017
Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella RP ...
Boston Scientific Launches Resonate Devices With HeartLogic Heart Failure Diagnostic
Technology | Implantable Cardioverter Defibrillator (ICD)| September 27, 2017
September 27, 2017 — Boston Scientific recently launched the Resonate family of...
BioCardia Announces 12-Month Results from TRIDENT Trial of Stem Cell Delivery System
News | Stem Cell Therapies| September 26, 2017
BioCardia Inc. recently announced 12-month results from the Phase II TRIDENT clinical trial, conducted by the...
CardiAMP Heart Failure Trial Design Presented at Texas Heart Institute Symposium
News | Heart Failure| September 25, 2017
BioCardia Inc. announced the trial design for its pivotal Phase III CardiAMP Heart Failure Trial was presented during...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
Heart Failure Market to Surpass $16 Billion by 2026
News | Heart Failure| September 19, 2017
The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Overlay Init